<sup>131</sup>I-RP215 McAb分子探针的制备、鉴定及荷人肺腺癌裸鼠放射免疫显像

吴梦雪; 雷成明; 谭祖稳; 张辉; 唐嘉励; 段东

doi:10.16016/j.1000-5404.201711070

您当前的位置：

首页 >

文章列表页 >

¹³¹I-RP215 McAb分子探针的制备、鉴定及荷人肺腺癌裸鼠放射免疫显像

基础医学 | 更新时间：2026-01-09

- ¹³¹I-RP215 McAb分子探针的制备、鉴定及荷人肺腺癌裸鼠放射免疫显像
- Preparation and identification of ¹³¹I-RP215 McAb molecular probe and its application for radioimmunoimaging in lung adenocarcinoma-bearing nude mice
- 第三军医大学学报 2018年40卷第7期页码：584-589
- 作者机构：
  
  400016 重庆, 重庆医科大学附属第一医院核医学科
- 作者简介：
  
  [段东，E-mail: duandong26@163.com DUAN Dong, E-mail: duandong26@163.com
- 基金信息：
  
  重庆市自然科学基金面上项目(CSTC2014jcyjA10012);重庆市科技计划项目(渝科发计〔2014〕21号);国家临床重点专科建设项目(国卫办医函〔2013〕544号)
- DOI：10.16016/j.1000-5404.201711070
  中图分类号： R392-33;R734.2;R817.4
- 收稿：2017-11-10，
  
  修回：2017-12-06，
  
  纸质出版：2018-04-15
- 稿件说明：
移动端阅览
吴梦雪, 雷成明, 谭祖稳, 等. ¹³¹I-RP215 McAb分子探针的制备、鉴定及荷人肺腺癌裸鼠放射免疫显像[J]. 第三军医大学学报, 2018,40(7):584-589.

Mengxue WU, Chengming LEI, Zuwen TAN, et al. Preparation and identification of ¹³¹I-RP215 McAb molecular probe and its application for radioimmunoimaging in lung adenocarcinoma-bearing nude mice[J]. Journal of Third Military Medical University, 2018, 40(7): 584-589.
吴梦雪, 雷成明, 谭祖稳, 等. ¹³¹I-RP215 McAb分子探针的制备、鉴定及荷人肺腺癌裸鼠放射免疫显像[J]. 第三军医大学学报, 2018,40(7):584-589. DOI： 10.16016/j.1000-5404.201711070.

Mengxue WU, Chengming LEI, Zuwen TAN, et al. Preparation and identification of ¹³¹I-RP215 McAb molecular probe and its application for radioimmunoimaging in lung adenocarcinoma-bearing nude mice[J]. Journal of Third Military Medical University, 2018, 40(7): 584-589. DOI： 10.16016/j.1000-5404.201711070.

摘要

目的

制备靶向肺腺癌细胞表面碳水化合物相关抗原(carbohydrate antigen 215，CA215)的核素分子探针

131

I-RP215单克隆抗体(monoclonal antibody

McAb)，鉴定其理化性质并探讨其在荷瘤裸鼠模型中的体内分布情况和放射免疫显像特点。

方法

采用氯胺T法对McAb RP215进行

131

I标记，Sephadex G25M柱纯化标记抗体，并鉴定其理化特性，观察该抗体标记物在荷A549裸鼠模型中的生物分布及放射免疫显像情况。

结果

131

I-RP215 McAb标记率为(91.03±2.36)%，纯化后的放化纯度为(93.15±1.40)%，比活度(3.37±0.42)MBq/μg；具有较好的稳定性及免疫活性。荷瘤裸鼠体内生物分布及SPECT显像结果显示，

131

I-RP215 McAb能够在肿瘤组织中选择性浓聚，

131

I-RP215 McAb作用24 h时，肿瘤/肌肉比达最高，且瘤体显影最清晰。

结论

成功制备了特性理想的

131

I-RP215 McAb分子探针，在荷人肺腺癌裸鼠模型中有较好的显像效果。

Abstract

Objective

To prepare a targeted probe for nuclide labeling of

131

I-RP215 monoclonal antibody (McAb) against carbohydrate-associated antigen

carbohydrate antigen 215 (CA215) which are expressed on the surface of lung adenocarcinoma cells

identify the physico-chemical properties of the probe

and to explore its distribution

in vivo

and radioimmunoimaging (RII) characteristics in tumor-bearing nude mice model.

Methods

McAb RP215 was labeled with

131

I by the chloramine T method

and then the products were purified with the Sephadex G25M column. The physico-chemical properties of the obtained McAbs were studied. Nude mice model bearing human lung adenocarcinoma was established by transplantation of A549 cells. Then the mice received the injection of

131

I-RP215 McAbs

via

tail vein

and the bio-distribution and RII characteristics were observed with single-photon emission computerized tomography (SPECT).

Results

The obtained

131

I-RP215 McAbs showed a labeling rate of (91.03±2.36)%

a radiochemical purity of (93.15±1.40)%

and a specific activity of 3.37±0.42 MBq/μg

and had good stabilities and immunological competence. Biodistribution and SPECT imaging showed

131

I-RP215 selectively accumulated in tumor tissue

and the target/non-target (T/NT) ratio reached the highest with the clearest tumor imaging at 24 h after injection of McAbs.

Conclusion

Molecular probes

131

I-RP215 McAbs

with ideal physicochemical properties are successfully prepared

and show satisfactory SPECT imaging in tumor-bearing nude mice.

关键词

Keywords

references

LEE G, ZHU M, GE B, et al . Widespread expressions of immunoglobulin superfamily proteins in cancer cells[J ] . Cancer Immunol Immunother, 2012, 61(1): 89-99. DOI: 10.1007/s00262-011-1088-1.

LEE G. Cancer cell-expressed immunoglobulins: CA215 as a pan cancer marker and its diagnostic applications[J]. Cancer Biomark, 2009, 5(3):137-142. DOI: 10.3233/CBM-2009-0610.

LEE G, LAFLAMME E, CHIEN C H, et al . Molecular identity of a pan cancer marker, CA215[J ] . Cancer Biol Ther, 2008, 7(12): 2007-2014. DOI: 10.4161/cbt.7.12.6984.

LEE G, WU Q, LI C H, et al . Recent studies of a new carbohydrate-associated pan cancer marker, CA215[J ] . J Clin Ligand Assay, 2006, 29(1): 47-51.

LEE G, GE B, HUANG T K, et al . Positive identification of CA215 pan cancer biomarker from serum specimens of cancer patients[J ] . Cancer Biomark, 2010, 6(2): 111-117. DOI:10.3233/CBM-2009-0134.

LEE G, AZADI P. Peptide mapping and glycoanalysis of cancer cell-expressed glycoproteins CA215 recognized by RP215 monoclonal antibody[J]. J Carbohyd Chem, 2012, 31(1): 10-30.

LIAO Q, LIU W, LIU Y, et al . Aberrant high expression of immunoglobulin G in epithelial stem/progenitor-like cells contributes to tumor initiation and metastasis[J ] . Oncotarget, 2015, 6(37):40081-40094. DOI: 10.18632/oncotarget.5542.

LEE G, CHEUNG A P, LI B, et al . Molecular and immuno-characteristics of immunoglobulin-like glycoproteins in cancer cell-expressed biomarker, CA215[J ] . Immunol Invest, 2012, 41(4):429-446. DOI:10.3109/08820139.2012.661007.

LEE G, ZHU M, GE B. Potential monoclonal antibody therapy for the treatment of ovarian cancer[M]//FARGHALY S A. Ovarian cancer—basic science perspective. Rijeka: Tech-Open Access Publisher, 2012: 385-406.

LEE G, GE B. Inhibition of in vitro tumor cell growth by RP215 monoclonal antibody and antibodies raised against its anti-idiotype antibodies[J ] . Cancer Immunol Immunother, 2010, 59(9):1347-1356.DOI:10.1007/s00262-010-0864-7.

LEE G, CHU R A, TING H H. Preclinical assessment of anti-cancer drugs by using RP215 monoclonal antibody[J]. Cancer Biol Ther, 2009, 8(2):161-166. DOI:10.4161/cbt.8.2.7117.

LIU Y, LIU D, WANG C, et al . Binding of the monoclonal antibody RP215 to immunoglobulin G in metastatic lung adenocarcinomas is correlated with poor prognosis[J ] . Histopathology, 2015, 67(5):645-653. DOI:10.1111/his.12686.

LEE G, GE B. Cancer cell expressions of immunoglobulin heavy chains with unique carbohydrate-associated biomarker[J]. Cancer Biomark, 2009, 5(4): 177-188. DOI:10.3233/CBM-2009-0102.

HUDSON P J, SOURIAU C. Engineered antibodies[J]. Nat Med, 2003, 9(1): 129-134. DOI:10.1038/nm0103-129.

REITER Y, SCHUCK P, BOYD L F, et al .An antibody single-domain phage display library of a native heavy chain variable region: isolation of functional single-domain VH molecules with a unique interface[J ] . J Mol Biol, 1999, 290(3):685-698. DOI:10.1006/jmbi.1999.2923.

YU F, WANG Y, XIAO Y, et al . RP215 single chain fragment variable and single domain recombinant antibodies induce cell cycle arrest at G 0 /G 1 phase in breast cancer[J ] .Mol immuno l, 2014, 59(1):100-109. DOI:10.1016/j.molimm.2014.01.007..

庞华. 肺腺癌人源噬菌体单链抗体制备及其在荷人肺腺癌裸鼠模型中的放免显像[D]. 重庆: 重庆医科大学, 2008.

PANG H. The construction of human single-chain variable fragment antibodies of lung adenocarcinoma and its radioimmunoimaging in bearing cancer nude mice[D]. Chongqing: Chongqing Medical University, 2008.

王洁, 李建国, 庞华, 等.抗HIF-1α肺腺癌人源单链抗体的制备和放射免疫显像[J].第三军医大学学报, 2010, 32(17):1851-1853.DOI: 10.16016/j.1000-5404. 2010.17.033.

WANG J, LI J G, PANG H, et al . Preparation of human anti-HIF-1α scFv of lung adenocarcinoma and its radioimmunoimaging[J ] . J Third Mil Med Univ, 2010, 32(17): 1851-1853. DOI: 10.16016/j.1000-5404.2010. 17.033.

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

抗HIF-1α肺腺癌人源单链抗体的制备和放射免疫显像

肺腺癌相关tsRNA的筛选和验证

局部晚期或转移性肺腺癌罕见基因突变患者的临床特征和生存分析

基于转录组学数据和堆叠监督自编码器的肺腺癌预后预测研究

腺苷脱氨酶1在肺腺癌组织中的表达及临床意义

131I-RP215 McAb分子探针的制备、鉴定及荷人肺腺癌裸鼠放射免疫显像

Preparation and identification of 131I-RP215 McAb molecular probe and its application for radioimmunoimaging in lung adenocarcinoma-bearing nude mice

DOI：10.16016/j.1000-5404.201711070

摘要

Abstract

关键词

Keywords

references

¹³¹I-RP215 McAb分子探针的制备、鉴定及荷人肺腺癌裸鼠放射免疫显像

Preparation and identification of ¹³¹I-RP215 McAb molecular probe and its application for radioimmunoimaging in lung adenocarcinoma-bearing nude mice